DE69412760D1 - Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen - Google Patents

Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen

Info

Publication number
DE69412760D1
DE69412760D1 DE69412760T DE69412760T DE69412760D1 DE 69412760 D1 DE69412760 D1 DE 69412760D1 DE 69412760 T DE69412760 T DE 69412760T DE 69412760 T DE69412760 T DE 69412760T DE 69412760 D1 DE69412760 D1 DE 69412760D1
Authority
DE
Germany
Prior art keywords
pct
cyclodextrines
inclusion complexes
complexes
nimesulide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69412760T
Other languages
English (en)
Other versions
DE69412760T2 (de
Inventor
Joseph Geczy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EUROPHARMACEUTICALS SA
CYCLOLAB Ltd
Original Assignee
EUROPHARMACEUTICALS SA
CYCLOLAB Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EUROPHARMACEUTICALS SA, CYCLOLAB Ltd filed Critical EUROPHARMACEUTICALS SA
Publication of DE69412760D1 publication Critical patent/DE69412760D1/de
Application granted granted Critical
Publication of DE69412760T2 publication Critical patent/DE69412760T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69412760T 1993-05-24 1994-05-18 Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen Expired - Fee Related DE69412760T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9301518A HU210922B (en) 1993-05-24 1993-05-24 Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
PCT/HU1994/000014 WO1994028031A1 (en) 1993-05-24 1994-05-18 New nimesulide salt cyclodextrin inclusion complexes

Publications (2)

Publication Number Publication Date
DE69412760D1 true DE69412760D1 (de) 1998-10-01
DE69412760T2 DE69412760T2 (de) 1999-05-20

Family

ID=10983630

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69412760T Expired - Fee Related DE69412760T2 (de) 1993-05-24 1994-05-18 Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen

Country Status (17)

Country Link
US (1) US5744165A (de)
EP (1) EP0656015B1 (de)
JP (1) JPH07509498A (de)
KR (1) KR950702580A (de)
AT (1) ATE170194T1 (de)
AU (1) AU675146B2 (de)
CA (1) CA2140887C (de)
CZ (1) CZ285962B6 (de)
DE (1) DE69412760T2 (de)
DK (1) DK0656015T3 (de)
ES (1) ES2124893T3 (de)
FI (1) FI950294A0 (de)
HU (1) HU210922B (de)
NO (1) NO307570B1 (de)
RU (1) RU2129564C1 (de)
SI (1) SI0656015T1 (de)
WO (1) WO1994028031A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0685461A4 (de) * 1993-02-19 1996-08-14 Taisho Pharmaceutical Co Ltd 5-aminoacetylaminosulfonanilidverbindung.
HUP9601442A3 (en) * 1995-07-25 1999-03-29 Panacea Biotec Ltd Nes antinflammatory and analgetic pharmaceutical compositions, containing nimesulid for transdermal use, and process for producing them
UA57734C2 (uk) 1996-05-07 2003-07-15 Пфайзер Інк. Комплекси включення арилгетероциклічних солей
IN186315B (de) * 1996-12-12 2001-08-04 Panacea Biotec Ltd
ES2129010B1 (es) * 1997-01-02 2000-01-16 Gold Oscar Composicion de accion prolongada en granulos que contienen 4-nitro-2- fenoximetansulfonanilida y su procedimiento de preparacion.
IT1291895B1 (it) 1997-04-24 1999-01-21 Errekappa Euroterapici S P A Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
IT1298221B1 (it) * 1998-02-10 1999-12-20 Helsinn Healthcare Sa Sali micronizzati di nimesulide
IT1318588B1 (it) * 2000-06-20 2003-08-27 Helsinn Healthcare Sa Uso della nimesulide nel trattamento di patologie dermatologiche.
EP1172101A1 (de) * 2000-06-20 2002-01-16 Helsinn Healthcare S.A. Verwendung von Nimesulfid zur Behandlung von Psoriasis und psoriatischer Arthritis
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
MXPA05002444A (es) 2002-09-06 2005-09-30 Insert Therapeutics Inc Polimeros a base de ciclodextrina para el suministro de agentes terapeuticos.
EP1549269A4 (de) 2002-10-09 2010-10-06 Cerulean Pharma Inc Materialien auf cyclodextrin-basis, zusammensetzungen und ihre verwendung
CN1511828A (zh) * 2002-12-31 2004-07-14 �й������ž�����ҽѧ��ѧԺ����ҽ 磺酰苯胺类衍生物及其医药用途
DE102004060914A1 (de) * 2004-12-17 2006-07-06 Bioghurt Biogarde Gmbh & Co. Kg Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス, インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN109608370A (zh) * 2019-01-22 2019-04-12 山西康斯亚森生物科技有限公司 尼美舒利衍生物和制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1248475B (it) * 1990-05-22 1995-01-19 Angeli Inst Spa Composti di inclusione di nimesulide con ciclodestrine

Also Published As

Publication number Publication date
HU9301518D0 (en) 1993-09-28
NO950243D0 (no) 1995-01-23
EP0656015A1 (de) 1995-06-07
WO1994028031A1 (en) 1994-12-08
RU95105977A (ru) 1997-02-10
RU2129564C1 (ru) 1999-04-27
KR950702580A (ko) 1995-07-29
AU7081394A (en) 1994-12-20
CZ16395A3 (en) 1995-10-18
CA2140887C (en) 2000-08-01
JPH07509498A (ja) 1995-10-19
NO950243L (no) 1995-03-13
AU675146B2 (en) 1997-01-23
SI0656015T1 (en) 1999-02-28
US5744165A (en) 1998-04-28
FI950294A (fi) 1995-01-24
ES2124893T3 (es) 1999-02-16
HU210922B (en) 1995-09-28
DE69412760T2 (de) 1999-05-20
HUT68239A (en) 1995-06-28
FI950294A0 (fi) 1995-01-24
CA2140887A1 (en) 1994-12-08
CZ285962B6 (cs) 1999-12-15
DK0656015T3 (da) 1999-05-25
ATE170194T1 (de) 1998-09-15
NO307570B1 (no) 2000-04-25
EP0656015B1 (de) 1998-08-26

Similar Documents

Publication Publication Date Title
DE69412760D1 (de) Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
DK0671912T3 (da) Injicerbare præparater baseret på taxanderivater
HN2000000109A (es) Trifluorbutenos nematicidas
DK0521900T3 (da) Alfa-cyanacrylatklæbestofsammensætninger
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
TR27835A (tr) Sübstitüe edilmis azadiokzasikloalkenler.
ES2097174T3 (es) Derivados de la 2-ciclohexan-1-il amina.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
DK0559690T3 (da) 8-en-19,11Beta-broholdige steroider, deres fremstilling og farmaceutiske præparater, som indeholder dem
PT96849A (pt) Processo de preparacao de novos derivados da beta-fenil-iso-serina e de beta-fenil-iso-serina-(2r,2s)
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
AU667294B2 (en) Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals
DE69614552T2 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
ES2122184T3 (es) Utilizacion de derivados de la benzomorfolina en composiciones cosmeticas o dermofarmaceuticas con accion despigmentante.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee